Overview

A Study of JNJ-70033093 and Digoxin in Healthy Participants

Status:
Recruiting
Trial end date:
2021-07-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the potential pharmacokinetic (PK) interaction between JNJ-70033093 and digoxin in healthy participants after single dose administration and at steady state.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Research & Development, LLC
Collaborator:
Bristol-Myers Squibb
Treatments:
Digoxin